Optec International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPTI research report →
Price Chart
About the company
Optec International, Inc. specializes in the global distribution and promotion of its advanced fuel optimization devices. These sophisticated units cater to a wide array of vehicles and equipment, including passenger cars, light and medium-duty trucks, various off-road machinery, power generation systems, heavy-duty diesel highway vehicles, and refrigerated transportation units.
- CEO
- Gregg Boehmer
- IPO
- 2016
- Employees
- 1
- HQ
- Carlsbad, CA, US
Get TickerSpark's AI analysis on OPTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.22M
- P/E
- -3.25
- PEG
- -0.03
- P/S
- 1.02
- P/B
- 3.34
- EV/EBITDA
- -44.98
- Div Yield
- 0.00%
- Gross Margin
- 72.97%
- Op Margin
- -25.03%
- Net Margin
- -61.74%
- ROE
- -88.27%
- ROIC
- -3.36%
Latest fiscal year · YoY change
- Revenue
- $2.19M-61.6%
- Gross Profit
- $1.60M+382.0%
- Op Income
- $-547,698
- Net Income
- $-1,351,099-136.3%
- EPS
- $-0.00-109.3%
- OCF Growth
- +83.7%
- FCF Growth
- +85.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.49
- RSI (14)
- 42
- Avg Volume
- 1.19M
No earnings-call transcripts are available for OPTI yet.
- Free Float
- 94.2%
- Shares Outstanding
- 1.71B
- Float Shares
- 1.61B
Our OPTI coverage
Recent articles, reports, and earnings notes.
No research on OPTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OPTI report →Optimi Health to Present at the ThinkEquity Conference
globenewswire.com · Oct 7
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
globenewswire.com · Sep 23
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
globenewswire.com · Sep 22
Optimi Health Establishes Discretionary Equity Facility
globenewswire.com · Aug 14
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
globenewswire.com · Jun 16
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
globenewswire.com · Jun 8
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
globenewswire.com · May 29
Diamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)
globenewswire.com · May 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.